https://www.bioworld.com/rss en-us http://www.bioworld.com/articles/728987 Thu, 12 Feb 2026 12:00:00 -0500 https://www.bioworld.com/articles/728987-abbvie-claims-cms-selection-of-botox-violates-the-ira http://www.bioworld.com/articles/715509 Tue, 17 Dec 2024 12:00:00 -0500 https://www.bioworld.com/articles/715509-gc-biopharma-to-buy-abo-holdings-for-138b-grow-us-plasma-biz http://www.bioworld.com/articles/715343 Fri, 13 Dec 2024 12:00:00 -0500 https://www.bioworld.com/articles/715343-gc-biopharma-to-buy-abo-holdings-for-138b-grow-us-plasma-biz http://www.bioworld.com/articles/434372 Mon, 13 Apr 2020 13:00:00 -0400 https://www.bioworld.com/articles/434372-stony-brook-chembio-diagnostics-partner-on-covid-19-trial 4-13-Chembio-Stony-Brook.png Led by Elliott Bennett-Guerrero at Stony Brook Medicine, the clinical trial is expected to enroll up to 500 patients who are hospitalized with COVID-19. Credit: Stony Brook Medicine